Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$22,745,806
+$929,782 QoQ
Shares Held
89,561
+0.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
2.22%
of 13F equity value
Holder Rank
#689
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TOWER BRIDGE ADVISORS holds $63,752,721 across 8 Drug Manufacturers - General names. JNJ ranks #1 (35.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
89,561 | $22,745,806 | |
| 2 | NVS |
Novartis AG
|
69,416 | $10,878,875 | |
| 3 | ABBV |
AbbVie Inc.
|
38,900 | $9,788,796 | |
| 4 | LLY |
ELI LILLY & Co
|
6,601 | $7,917,438 | |
| 5 | AMGN |
Amgen Inc
|
15,102 | $5,468,736 | |
| 6 | MRK |
Merck & Co., Inc.
|
34,852 | $4,478,482 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
26,527 | $1,528,485 | |
| 8 | PFE |
Pfizer Inc
|
39,290 | $946,103 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,745,806 | 89,561 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $21,816,024 | 89,249 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $18,171,244 | 87,805 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $17,067,540 | 92,048 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $14,110,128 | 92,374 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $16,008,203 | 96,528 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $14,324,466 | 99,049 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $16,206,000 | 100,000 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $15,001,131 | 102,635 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $17,455,317 | 110,344 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $19,905,039 | 126,994 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $20,156,542 | 129,416 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $21,739,396 | 131,340 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $29,823,395 | 192,409 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $34,323,624 | 194,303 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $31,903,064 | 195,293 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $34,965,387 | 196,977 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $35,511,929 | 200,372 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $34,158,060 | 199,673 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $32,092,957 | 198,718 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $32,652,785 | 198,208 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $33,001,644 | 200,801 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $32,289,025 | 205,166 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $28,623,371 | 192,258 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $27,256,062 | 193,814 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $25,374,441 | 193,506 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||